Australia and New Zealand

Since 1993, Quintiles Australia and New Zealand have provided fully integrated services for Phase II-IV clinical studies to the pharmaceutical industry. These locations are part of our infrastructure that enables the transfer of best practices around the globe.

Read more about:

Case Study

Energizing Enrollment

The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned.

Learn more

Fact Sheet

Australia and New Zealand Phase II/III Fact Sheet

Australia and New Zealand fact sheet around Phase II/III trials. Same language. Same technology. Same quality standards.

Read more